Biodesix, Inc. (BDSX)

USD 0.5

(0.6%)

Total Assets Summary of Biodesix, Inc.

  • Biodesix, Inc.'s latest annual total assets in 2023 was 99.09 Million USD , up 6.66% from previous year.
  • Biodesix, Inc.'s latest quarterly total assets in 2024 Q3 was 102.74 Million USD , down -11.31% from previous quarter.
  • Biodesix, Inc. reported annual total assets of 92.9 Million USD in 2022, up 22.09% from previous year.
  • Biodesix, Inc. reported annual total assets of 76.09 Million USD in 2021, down -37.15% from previous year.
  • Biodesix, Inc. reported quarterly total assets of 115.84 Million USD for 2024 Q2, up 32.84% from previous quarter.
  • Biodesix, Inc. reported quarterly total assets of 87.2 Million USD for 2024 Q1, down -12.0% from previous quarter.

Annual Total Assets Chart of Biodesix, Inc. (2023 - 2018)

Historical Annual Total Assets of Biodesix, Inc. (2023 - 2018)

Year Total Assets Total Assets Growth
2023 99.09 Million USD 6.66%
2022 92.9 Million USD 22.09%
2021 76.09 Million USD -37.15%
2020 121.07 Million USD 190.8%
2019 41.63 Million USD 6.6%
2018 39.05 Million USD 0.0%

Peer Total Assets Comparison of Biodesix, Inc.

Name Total Assets Total Assets Difference
Castle Biosciences, Inc. 477.81 Million USD 79.26%
Exact Sciences Corporation 6.47 Billion USD 98.469%
IDEXX Laboratories, Inc. 3.25 Billion USD 96.96%
23andMe Holding Co. 395.16 Million USD 74.923%
NeoGenomics, Inc. 1.68 Billion USD 94.106%
Neogen Corporation 4.58 Billion USD 97.838%
Inotiv, Inc. 856.53 Million USD 88.431%
Psychemedics Corporation 13.27 Million USD -646.767%
RadNet, Inc. 2.88 Billion USD 96.567%
Star Equity Holdings, Inc. 86.97 Million USD -13.937%
bioAffinity Technologies, Inc. 8.22 Million USD -1105.32%
Illumina, Inc. 10.11 Billion USD 99.02%
Aspira Women's Health Inc. 6.26 Million USD -1482.498%
Prenetics Global Limited 254.17 Million USD 61.012%
iSpecimen Inc. 15.81 Million USD -526.431%
OpGen, Inc. 1.88 Million USD -5164.696%
T2 Biosystems, Inc. 34.79 Million USD -184.783%
Standard BioTools Inc. 323.06 Million USD 69.326%
Neuronetics, Inc. 115.83 Million USD 14.448%
Precipio, Inc. 18.1 Million USD -447.461%
Intelligent Bio Solutions Inc. 13.77 Million USD -619.189%
Exagen Inc. 56.94 Million USD -74.024%
Bionano Genomics, Inc. 214.4 Million USD 53.781%
CareDx, Inc 484.61 Million USD 79.552%
Check-Cap Ltd. 25.01 Million USD -296.115%
Twist Bioscience Corporation 776.4 Million USD 87.237%
Guardant Health, Inc. 1.78 Billion USD 94.453%
BioNexus Gene Lab Corp. 11.39 Million USD -769.279%
Natera, Inc. 1.45 Billion USD 93.199%
Fulgent Genetics, Inc. 1.27 Billion USD 92.216%
Sera Prognostics, Inc. 95.44 Million USD -3.83%
OPKO Health, Inc. 2.01 Billion USD 95.074%
Personalis, Inc. 225.09 Million USD 55.977%
Aclaris Therapeutics, Inc. 197.4 Million USD 49.801%
Applied DNA Sciences, Inc. 13.65 Million USD -625.894%
Myriad Genetics, Inc. 1.19 Billion USD 91.733%
ICON Public Limited Company 16.98 Billion USD 99.417%
Star Equity Holdings, Inc. 86.97 Million USD -13.937%
MDxHealth SA 129.13 Million USD 23.26%
Prenetics Global Limited 254.17 Million USD 61.012%
DarioHealth Corp. 96.38 Million USD -2.808%
ENDRA Life Sciences Inc. 6.75 Million USD -1367.188%
Medpace Holdings, Inc. 1.65 Billion USD 94.019%
Mainz Biomed B.V. 15.4 Million USD -543.104%
Trinity Biotech plc 59.43 Million USD -66.73%
Sotera Health Company 3.13 Billion USD 96.834%
bioAffinity Technologies, Inc. 8.22 Million USD -1105.32%